Hjem › Ikke-småcellet lungekreft › Ohio › Akron
Kliniske studier for Ikke-småcellet lungekreft i Akron, OH
22 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Akron (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · 21 mi unna
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruttererFase 3
- Aultman Health Foundation, Canton · 21 mi unna
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RekruttererFase 3
- Akron General Medical Center, Akron
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Aultman North, North Canton · 15 mi unna
- Aultman Massillon, Massillon · 20 mi unna
- Aultman Orrville Hospital, Orrville · 21 mi unna
- og 2 flere
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
RekruttererFase 3
- Research Site, Canton · 21 mi unna
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruttererFase 3
- Aultman Hospital, Canton · 21 mi unna
Pan-tumor MRD Study
RekruttererObservasjonsstudie
- Gabrail Cancer Center, Canton · 21 mi unna
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekruttererFase 2/3
- Gabrail Cancer Center Research, Canton · 21 mi unna
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
RekruttererFase 2
- Gabrail Cancer Center, Canton · 21 mi unna
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruttererFase 2/3
- Tricounty Hematology and Oncology - Massillon, Massillon · 20 mi unna
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
RekruttererFase 1/2
- Gabrail Cancer Center Research, Canton · 21 mi unna
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RekruttererFase 3
- Gabrail Cancer Center, Canton · 21 mi unna
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RekruttererFase 2
- Gabrail Cancer and Research Center, Canton · 21 mi unna
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Cleveland Clinic Mercy Hospital, Canton · 21 mi unna
- Aultman Health Foundation, Canton · 21 mi unna
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Aultman Health Foundation, Canton · 21 mi unna
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Aultman Health Foundation, Canton · 21 mi unna
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- Aultman Health Foundation, Canton · 21 mi unna
GEMINI-NSCLC: NSCLC Biomarker Study
RekruttererObservasjonsstudie
- Aultman Hospital, Canton · 21 mi unna
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RekruttererFase 1
- Gabrail Cancer & Research Center, Canton · 21 mi unna
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site 138, Canton · 21 mi unna
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
RekruttererFase 1/2
- Gabrail Cancer Center Research, Canton · 21 mi unna
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
RekruttererFase 1/2
- Gabrail Cancer Research Center, Canton · 21 mi unna
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY120 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH56 studier
- Washington, DC55 studier
Andre studier i Akron
- Lungekreft16 studier
- Kreft (alle typer)13 studier
- Brystkreft13 studier
- Prostatakreft9 studier
- Akut myelogen leukemi8 studier
- Melanom8 studier
- Småcellet lungekreft8 studier
- Metastatisk kreft8 studier
- Kolorektal kreft8 studier
- Steatotisk leversykdom7 studier
- Endometriekreft6 studier
- Eggstokkreft6 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.